The Role of MRI in Pharmacology and Drug Development

08:15 – 09:30

Chairs: Andre Duerinckx and Arend Heerschap

Educational Objectives

Upon completion of this session participants should be able to:

• Summarize the use of MRI and MRS in preclinical pharmaceutical research;
• Identify trends in the use of MR for pharmacological investigations;
• Describe the impact and perspectives of imaging in research, diagnosis and treatment of drug addiction;
• Recognize the impact of genetic engineering and gene therapy on future drug development;
• Describe the current role of MRI and its future potential contributions in gene therapy.

08:15 595. Magnetic Resonance in Pharmaceutical Research, Marcus Rudin, Novartis Pharma AG, Basel, Switzerland.
08:40 596. Neuroimaging in Drug Addiction, Francis Vocci, National Institute on Drug Abuse, Rockville, MD, USA.
09:05 597. Imaging of Gene Expression, Ralph Weissleder, Massachusetts General Hospital, Boston, MA, USA.

Return to ISMRM program